Trending
Dell shares have roughly quadrupled in 2024, outpacing Micron and AMD. Lenovo’s latest earnings report pushed Dell’s gains further as demand signals align.
Birkenstock raised its full-year revenue forecast Wednesday, citing resilient full-price demand from affluent shoppers for its premium sandals.
VanEck’s Pharma ETF offers lower costs and stability; Invesco’s Biotech ETF chases higher returns with steeper risk. Which fits your portfolio?
Trump’s vaccine executive order is raising alarms among pediatricians as measles spreads, immunization rates fall, and children return to school.
On Holding cut its full-year sales outlook, missing expectations and sending shares lower premarket. Roger Federer’s equity stake fell with the stock.
Tesla is recalling 20,349 U.S. vehicles over low-beam headlights that may be too bright, posing a crash risk to oncoming drivers, per NHTSA.
Birkenstock raised its full-year revenue forecast Wednesday, citing resilient full-price demand from affluent shoppers for its premium sandals.
Tesla is recalling 20,349 U.S. vehicles over low-beam headlights that may be too bright, posing a crash risk to oncoming drivers, per NHTSA.
Just In
Dell shares have roughly quadrupled in 2024, outpacing Micron and AMD. Lenovo’s latest earnings report pushed Dell’s gains further as demand signals align.
Clothing retailers are offering repairs and sewing workshops to attract Gen Z shoppers motivated by both saving money and reducing environmental waste.
The U.S. Senate passed a resolution adding Missouri to the 1960 college football national title claimants, raising questions about legislative resources and athletic prestige economics.
The U.S. suspended all operations in Michoacan over an unspecified security threat, halting avocado inspections needed for exports to American markets.
Finance
VanEck’s Pharma ETF offers lower costs and stability; Invesco’s Biotech ETF chases higher returns with steeper risk. Which fits your portfolio?
Editor's Picks
Retail insider Vecchio sold $620K in stock under a preplanned Rule 10b5-1 schedule while retaining 77,661 shares valued at $28.60 million.
Latest
Chewy CEO Sumit Singh sold 81,841 shares for $1.9M under a pre-arranged January plan, trimming his stake 8% while retaining nearly $20.5M in holdings.
